These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33836622)

  • 21. The effect of coaching on the simulated malingering of memory impairment.
    Rüsseler J; Brett A; Klaue U; Sailer M; Münte TF
    BMC Neurol; 2008 Oct; 8():37. PubMed ID: 18838010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. When Time is of the Essence: Preliminary Findings for a Quick Administration of the Dot Counting Test.
    Bailey KC; Webber TA; Phillips JI; Kraemer LDR; Marceaux JC; Soble JR
    Arch Clin Neuropsychol; 2021 Apr; 36(3):403-413. PubMed ID: 31740920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Test of memory malingering with children: The utility of Trial 1 and TOMMe10 as screeners of test validity.
    Loughan AR; Perna R; Le J
    Child Neuropsychol; 2016; 22(6):707-17. PubMed ID: 26031205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Examining independent and combined accuracy of embedded performance validity tests in the California Verbal Learning Test-II and Brief Visuospatial Memory Test-Revised for detecting invalid performance.
    Resch ZJ; Pham AT; Abramson DA; White DJ; DeDios-Stern S; Ovsiew GP; Castillo LR; Soble JR
    Appl Neuropsychol Adult; 2022; 29(2):252-261. PubMed ID: 32202916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An examination of the frequency of invalid forgetting on the Test of Memory Malingering.
    Buddin WH; Schroeder RW; Hargrave DD; Von Dran EJ; Campbell EB; Brockman CJ; Heinrichs RJ; Baade LE
    Clin Neuropsychol; 2014; 28(3):525-42. PubMed ID: 24742358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficiency and accuracy of the Test of Memory Malingering trial 1, errors on the first 10 items of the test of memory malingering, and five embedded measures in predicting invalid test performance.
    Denning JH
    Arch Clin Neuropsychol; 2012 Jun; 27(4):417-32. PubMed ID: 22543569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A pilot study on the adequacy of the TOMM in detecting invalid performance in patients with substance use disorders.
    Vilar-López R; Daugherty JC; Pérez-García M; Piñón-Blanco A
    J Clin Exp Neuropsychol; 2021 Apr; 43(3):255-263. PubMed ID: 33855936
    [No Abstract]   [Full Text] [Related]  

  • 28. Utility of abbreviated versions of the test of memory malingering in children with traumatic brain injury.
    Donders J; Gardner V
    Appl Neuropsychol Child; 2020; 9(4):355-359. PubMed ID: 32401052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Derivation and clinical validation of consistency indices on the test of memory malingering.
    Davis JJ; Wall JR; Whitney KA
    Arch Clin Neuropsychol; 2012 Nov; 27(7):706-15. PubMed ID: 22951670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is the Rey 15-Item Memory Test II (Rey II) a valid symptom validity test?: comparison with the TOMM.
    Whitney KA; Hook JN; Steiner AR; Shepard PH; Callaway S
    Appl Neuropsychol; 2008; 15(4):287-92. PubMed ID: 19023746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Known-Groups Validation of the Medical Symptom Validity Test and Analysis of the Genuine Memory Impairment Profile.
    Resch ZJ; Rhoads T; Ovsiew GP; Soble JR
    Assessment; 2022 Apr; 29(3):455-466. PubMed ID: 33371720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing sub-optimal performance with the Test of Memory Malingering in Spanish speaking patients with TBI.
    Strutt AM; Scott BM; Lozano VJ; Tieu PG; Peery S
    Brain Inj; 2012; 26(6):853-63. PubMed ID: 22583176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of criterion measures on the classification accuracy of TOMM-1.
    Rai JK; Erdodi LA
    Appl Neuropsychol Adult; 2021; 28(2):185-196. PubMed ID: 31187632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detecting symptom- and test-coached simulators with the test of memory malingering.
    Powell MR; Gfeller JD; Hendricks BL; Sharland M
    Arch Clin Neuropsychol; 2004 Aug; 19(5):693-702. PubMed ID: 15271412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Not so fast! Limitations of processing speed and working memory indices as embedded performance validity tests in a mixed neuropsychiatric sample.
    Ovsiew GP; Resch ZJ; Nayar K; Williams CP; Soble JR
    J Clin Exp Neuropsychol; 2020 Jul; 42(5):473-484. PubMed ID: 32498648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hit rates of adequate performance based on the test of memory malingering (TOMM) Trial 1.
    Gavett BE; O'Bryant SE; Fisher JM; McCaffrey RJ
    Appl Neuropsychol; 2005; 12(1):1-4. PubMed ID: 15788216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The validity of the test of memory malingering (TOMM) with deaf individuals.
    Chovaz CJ; Rennison VLA; Chorostecki DO
    Clin Neuropsychol; 2021 Apr; 35(3):597-614. PubMed ID: 31797722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic accuracy of a bayesian latent group analysis for the detection of malingering-related poor effort.
    Ortega A; Labrenz S; Markowitsch HJ; Piefke M
    Clin Neuropsychol; 2013; 27(6):1019-42. PubMed ID: 23767801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrospective Analysis of the Test of Memory Malingering in a Low Intellectual Quotient Intractable Epilepsy Sample.
    Grant AF; Werner NJ
    Arch Clin Neuropsychol; 2020 Aug; 35(6):726-734. PubMed ID: 32377674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Psychometric implications of failure on one performance validity test: a cross-validation study to inform criterion group definition.
    Rhoads T; Neale AC; Resch ZJ; Cohen CD; Keezer RD; Cerny BM; Jennette KJ; Ovsiew GP; Soble JR
    J Clin Exp Neuropsychol; 2021 Jul; 43(5):437-448. PubMed ID: 34233580
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.